As certain hospitals have started worrying about the quality of medicines produced by Ranbaxy, the company issued an advisory on Monday for patients, doctors and stakeholders. “Ranbaxy stands by the quality of every medicine that the company makes and distributes in India and every country around the world,” the company said in a statement.
The pharma major said it operated current good manufacturing practice-compliant facilities in India and other countries.
“The company’s India facilities are routinely inspected by the Drug Controller General of India and many other leading global regulatory agencies,” the release said, and added that the company was committed to its philosophy of ‘Quality and Patients First.’